| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.26 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |